Ramsay's results are just what the doctor ordered

Australia's largest private hospital owner has reported a 15% increase in profits.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ramsay Health Care (ASX: RHC), which owns and operates private hospitals around the world, has reported a 5.5% increase in revenues to $4.2 billion and a 15.1% jump in core net profit after tax (NPAT) to $290.9 million. The group result was largely thanks to a solid performance from the Australian and Indonesian divisions which contributed revenues of $3.4 billion, up 6.8% and earnings before interest and tax of $418.2 million, up 11.2%.

Highlights from the results included growth in the Australian hospital margins to 17.9%, growth in Indonesian margins to 17.8% and growth in both the UK and French divisional margins. Ramsay continues to boost its assets, acquiring a 531-bed hospital in Toulouse, France during the year, opening the $133 million Joondalup Private Hospital in Perth and approving $200 million in organic capacity expansions to be undertaken at current facilities during the year.

Concerns over Ramsay's relationship with Australia's largest private health insurer have also been eased with the company announcing that it had resolved its differences with Medibank Private. While not providing any details, terms for a three-year agreement have been reached.

It has been a good reporting season for many of the listed medical service providers. Primary Health Care (ASX: PRY) reported 29% growth in earnings to $150 million, Sonic Healthcare (ASX: SHL) boosted profits by 6% to $335 million, while micro-cap Capitol Health (ASX: CAJ) reported 100% growth in underlying NPAT to $3.6 million.

Foolish takeaway

Ramsay reported 17.1% growth in core earnings per share (EPS) to 135.9 cents and the share price has since rallied to $35.15 after the results were released, placing the stock on a hefty 25.9 times FY2013 earnings.

With the company boosting the full year dividend by 17.5% to 70.5 cents and forecasting growth in both core NPAT and core EPS of between 12% and 14% for the FY2014 it is understandable that the company trades at a premium to the market; however whether such a high premium is justified is debatable.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Tim McArthur owns shares in Primary Healthcare.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »